HomeDYN • NASDAQ
add
Dyne Therapeutics Inc
Previous close
$21.17
Day range
$20.59 - $22.29
Year range
$6.36 - $31.28
Market cap
3.13B USD
Avg Volume
2.85M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 113.89M | 7.79% |
Net income | -108.04M | -11.24% |
Net profit margin | — | — |
Earnings per share | -0.76 | 20.83% |
EBITDA | -113.37M | -7.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 791.89M | 9.43% |
Total assets | 867.06M | 12.77% |
Total liabilities | 175.28M | 176.88% |
Total equity | 691.78M | — |
Shares outstanding | 142.82M | — |
Price to book | 4.36 | — |
Return on assets | -35.68% | — |
Return on capital | -37.84% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -108.04M | -11.24% |
Cash from operations | -90.78M | -21.64% |
Cash from investing | -37.96M | -95.67% |
Cash from financing | 217.33M | 1,106.77% |
Net change in cash | 88.58M | 216.52% |
Free cash flow | -62.59M | -46.00% |
About
Founded
2017
Headquarters
Website
Employees
240
